RecruitingPhase 3NCT07383246
CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
Studying Medullary thyroid carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Principal Investigator
- Shaoyan Liu, MDChinese Academy of Medical Sciences
- Intervention
- 68Ga-CTR-FAPI PET-CT guided surgery(procedure)
- Enrollment
- 150 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2031
Study locations (1)
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing Municipality, China
Collaborators
Peking Union Medical College Hospital · Peking University Cancer Hospital & Institute · Peking University First Hospital · Xiangya Hospital of Central South University · Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07383246 on ClinicalTrials.govOther trials for Medullary thyroid carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07138716Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTCLuo Yaping
- ENROLLING BY INVITATIONNCT06852144PET-TC in Thyroid EvaluationIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNANCT06141369Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)Shanghai Jiao Tong University School of Medicine
- RECRUITINGNANCT0627718068Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGPHASE1NCT06520319Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid CarcinomaFirst Affiliated Hospital of Fujian Medical University
- RECRUITINGPHASE4NCT05830500Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- ACTIVE NOT RECRUITINGPHASE1NCT04877613GFRα4 CAR T Cells in MTC PatientsUniversity of Pennsylvania
- ACTIVE NOT RECRUITINGNANCT04522570Thermal Ablation of Cervical Metastases From Thyroid CarcinomaInstituto do Cancer do Estado de São Paulo